Alcon ALC
NYSE ALC
$70.66 +3.23 (+4.79%)
As of: Oct 22, 2026 · 3:59 PM EDT

Alcon (ALC) EV to EBITDA (2019)

Updated

Alcon's (ALC) EV to EBITDA stood at 11.41 in Q2 2026, down 29.0% from 16.07 a year earlier and down 14.3% from the prior quarter.

Analysis

Alcon (ALC) EV to EBITDA (2019) Analysis & Trends

On a TTM basis, Alcon's EV to EBITDA came in at 9.66 as of Jun 30, 2026, down 32.4% year-over-year; for FY2025, it was 14.16, down 5.8% from FY2024.

  • Annual EV to EBITDA has declined for five straight years.
  • Across earlier years, EV to EBITDA came in at 15.03 in FY2024 (-7.8%), 16.30 in FY2023 (-10.1%), 18.13 in FY2022 (-20.2%) and 22.72 in FY2021 (-14.8%).
  • The Q2 2026 figure is the lowest quarterly EV to EBITDA in data going back to Q2 2019.
  • On a year-over-year basis, EV to EBITDA rose in 1 of the last five quarters, with an average decline of 8.8%.
  • Peak year-over-year performance for EV to EBITDA in the last five years was growth of 27.9% in Q3 2023, against a decline of 62.8% in Q1 2022 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.71 Bn 229.74 Bn 4.88 Bn
2 Abbott Laboratories 178.38 Bn 148.81 Bn 7.27 Bn
3 Danaher 161.61 Bn 145.42 Bn 3.61 Bn
4 Intuitive Surgical 154.15 Bn 134.44 Bn 2.08 Bn
5 Medtronic 123.21 Bn 88.46 Bn 6.34 Bn
6 Stryker 117.50 Bn 103.61 Bn 4.50 Bn
7 Boston Scientific 67.50 Bn 62.26 Bn 3.85 Bn
8 Becton Dickinson 54.80 Bn 51.95 Bn 2.32 Bn
9 Edwards Lifesciences 51.78 Bn 35.79 Bn 1.35 Bn
10 Alcon 34.78 Bn 25.74 Bn 1.68 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 32.55
API Access

Alcon EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ALC&period=max&api_key=YOUR_API_KEY